X4 Pharmaceuticals (XFOR) Reports In-Line Q2 EPS

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q2 EPS of ($0.74), in-line with the analyst estimate of ($0.74).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Isabella Bank added to Russell 2000 index after Nasdaq listing
• Waste stocks ride AI and healthcare boom as CLH surges 27%